Señales en vivo de BWAY | Maximiza tus Ganancias con Getagraph.com

VENDER 117320 min ago

@ $6.41

Emitido: 13 feb 2024 @ 14:44

Retorno: -9.78%

Señal anterior: feb 13 - 12:47

Señal anterior: Comprar

Retorno: 0.03 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...

Stats
Volumen de hoy	19 564.00
Volumen promedio	95 201.00
Capitalización de mercado	96.16M
EPS	$0 ( 2024-03-06 )
Próxima fecha de ganancias	( $-0.0200 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.57
ATR14	$0.0330 (0.58%)

Volumen Correlación

Largo: -0.12 (neutral)

Corto: -0.85 (strong negative)

Signal:(45.165) Neutral

Brainsway Ltd. Correlación

10 Correlaciones Más Positivas
BFC	0.907
PLAB	0.894
CNTX	0.893
AMTX	0.892
RRBI	0.89
CBAT	0.889
KLIC	0.885
GETVV	0.88
PSCT	0.875
SHC	0.872

10 Correlaciones Más Negativas
IRTC	-0.897
PWUP	-0.86
AAPL	-0.846
VOXX	-0.845
SWBI	-0.836
PTCT	-0.835
RMRM	-0.832
BNIXU	-0.832
CPRT	-0.829
ENTX	-0.825

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Brainsway Ltd. Correlación - Moneda/Commodity

0.59
( weak )

0.00
( neutral )

0.29
( neutral )

-0.68
( moderate negative )

Brainsway Ltd. Finanzas

Annual	2023
Ingresos:	$31.79M
Beneficio Bruto:	$23.09M (72.65 %)
EPS:	$-0.250

FY	2023
Ingresos:	$31.79M
Beneficio Bruto:	$23.09M (72.65 %)
EPS:	$-0.250

FY	2022
Ingresos:	$27.18M
Beneficio Bruto:	$20.05M (73.77 %)
EPS:	$-0.870

FY	2021
Ingresos:	$29.66M
Beneficio Bruto:	$23.06M (77.75 %)
EPS:	$-0.420

Financial Reports:

No articles found.

Brainsway Ltd.

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.